AptarGroup Inc

Healthcare · Medical Instruments & Supplies

119.90$ -0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

AptarGroup Inc (ATR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,027 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement ATR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	590	539	601	618	624	626	703	711	666	685	744	743	701	671	722	699	759	749	777	811	825	814	845	845	837	796	860	896	893	838	915	910	909	848	887	966	961	963	983	1,027	3,933
Cost of Revenue	381	353	385	400	408	411	456	464	435	458	469	469	444	436	451	442	480	470	489	523	537	522	543	549	546	520	557	574	567	526	583	567	559	519	617	669	673	701	707	741	2,822
Gross Profit	209	186	216	218	216	215	248	246	230	228	275	273	257	236	270	258	279	279	288	288	288	292	302	296	290	276	303	322	326	312	333	343	351	329	271	297	288	262	276	286	1,112
Research & Development	87	66	0.0	96	96	68	0.0	107	104	75	–	114	112	83	293	123	122	93	134	141	136	277	146	135	135	128	148	141	138	93	153	149	142	139	155	306	455	151	168	158	932
Selling, General & Administrative	87	82	102	96	96	95	112	107	104	107	121	114	112	108	126	123	122	129	134	141	136	140	146	135	135	128	148	141	138	138	153	149	142	139	155	151	149	151	168	–	–
Total Operating Expenses	126	121	139	133	136	134	154	147	145	155	169	162	161	158	182	187	180	198	195	204	205	205	204	194	195	190	219	206	207	228	221	217	212	209	155	151	149	151	168	158	625
Operating Income	82	65	78	85	80	79	88	81	61	56	97	110	90	74	88	70	99	82	93	84	83	87	98	101	95	85	84	117	119	84	112	126	138	120	115	146	139	111	109	128	487
Interest Expense	8.8	8.7	8.3	7.7	9.7	15	8.1	8.0	8.7	7.9	9.2	8.8	8.9	8.6	8.4	8.7	8.9	7.3	7.4	7.2	8.0	7.7	8.9	12	9.8	10	10	9.7	10.0	11	10	10	12	11	11	11	14	17	17	16	63
Pre-Tax Income	75	61	69	80	70	76	81	75	51	59	90	102	82	68	78	61	89	73	101	74	66	80	87	89	85	74	73	111	110	81	104	118	131	116	106	140	154	92	94	115	454
Income Tax Expense	22	12	18	14	16	27	22	19	12	18	27	28	26	19	23	19	25	20	17	19	19	23	24	26	31	14	19	28	26	18	21	28	31	15	27	28	26	17	21	27	92
Net Income	53	50	52	65	54	50	59	56	39	41	63	74	57	49	55	42	64	53	84	55	47	58	62	64	54	59	55	83	84	62	83	90	100	101	79	112	128	74	73	88	363
EBITDA	123	109	115	125	119	130	131	124	103	120	147	159	140	127	137	126	153	139	166	139	134	148	154	160	152	143	143	183	183	156	179	193	210	195	183	220	243	185	186	208	822

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings